Childhood Malignant Mesenchymoma Completed Phase 3 Trials for Vincristine (DB00541)

IndicationStatusPhase
DBCOND0028728 (Childhood Malignant Mesenchymoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003958Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaTreatment